SageView Advisory Group’s Boston Scientific BSX Stock Holding History

SageView Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$744K	Sell	7,805 -2,770	-26%	-$272K	0.03%	294
2025 Q3	$1.03M	Sell	10,575 -224	-2%	-$23.2K	0.04%	264
2025 Q2	$1.14M	Buy	10,799 +386	+4%	+$39.1K	0.04%	224
2025 Q1	$1.05M	Buy	10,413 +702	+7%	+$70.7K	0.04%	218
2024 Q4	$867K	Buy	9,711 +450	+5%	+$39.6K	0.04%	242
2024 Q3	$776K	Buy	9,261 +259	+3%	+$20.4K	0.04%	230
2024 Q2	$693K	Buy	9,002 +820	+10%	+$60K	0.03%	282
2024 Q1	$560K	Sell	8,182 -1,396	-15%	-$89.8K	0.03%	301
2023 Q4	$588K	Buy	+9,578	New	+$511K	0.03%	361

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SageView Advisory Group's BSX Position: Q4 2025 in Review

SageView Advisory Group reduced its Boston Scientific (BSX) stake by 26% in Q4 2025, selling an estimated $272K and leaving 7,805 shares worth $744K. The position accounts for 0.03% of the portfolio, ranked #294.

SageView Advisory Group first reported a position in BSX in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.14M in Q2 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

SageView Advisory Group held 7,805 shares of Boston Scientific worth $744K as of Q4 2025.
SageView Advisory Group sold 2,770 Boston Scientific shares in Q4 2025, an estimated $272K.
Boston Scientific made up 0.03% of SageView Advisory Group's portfolio in Q4 2025, its #294 holding.
SageView Advisory Group first reported a position in Boston Scientific in Q4 2023 and has held it in 9 quarters since.
SageView Advisory Group's Boston Scientific position peaked at $1.14M in Q2 2025.
1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.